San Diego, CA · Founded 2024 · Privately Held (backing)
Operator of a biopharmaceutical company intended to develop and commercialize therapies for autoimmune diseases. Timberlyne Therapeutics is based in San Diego, CA and was founded in 2024. Its last reported valuation was $324 million in Jan 2025. It has raised $180 million.
Last reported valuation
$324.2M
Oct 2026
Priced at
—
Total raised
$180.0M
Last round
—
Team — not yet on record
No current team members for Timberlyne Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Timberlyne Therapeutics with a free account
·Watch Timberlyne Therapeutics: the Monday email on marks, rounds and moves
